| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6166781 | Urology | 2014 | 4 Pages |
Abstract
The novel provision of continuous steady-state ketorolac is safe for postoperative pain control in patients after donor nephrectomy, with no change in glomerular filtration rates between treatment and control groups acutely and at up to 1.5-year follow-up.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Gwen M. Grimsby, Paul E. Andrews, Erik P. Castle, Rafael Nunez, Laurie A. Mihalik, Yu-Hui H. Chang, Mitchell R. Humphreys,